Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
|
Buy Now
Coalitions and Compliance - The Political Economy of Pharmaceutical Patents in Latin America (Hardcover)
Loot Price: R3,193
Discovery Miles 31 930
|
|
Coalitions and Compliance - The Political Economy of Pharmaceutical Patents in Latin America (Hardcover)
Expected to ship within 12 - 17 working days
|
Coalitions and Compliance examines how international changes can
reconfigure domestic politics. Since the late 1980s, developing
countries have been subject to intense pressures regarding
intellectual property rights. These pressures have been
exceptionally controversial in the area of pharmaceuticals.
Historically, fearing the economic and social costs of providing
private property rights over knowledge, developing countries did
not allow drugs to be patented. Now they must do so, an obligation
with significant implications for industrial development and public
health. This book analyses different forms of compliance with this
new imperative in Latin America, comparing the politics of
pharmaceutical patenting in Argentina, Brazil, and Mexico.
Coalitions and Compliance focuses on two periods of patent
politics: initial conflicts over how to introduce drug patents, and
then subsequent conflicts over how these new patent systems
function. In contrast to explanations of national policy choice
based on external pressures, domestic institutions, or Presidents'
ideological orientations, this book attributes cross-national and
longitudinal variation to the ways that changing social structures
constrain or enable political leaders' strategies to construct and
sustain supportive coalitions. The analysis begins with assessment
of the relative resources and capabilities of the transnational and
national pharmaceutical sectors, and these rival actors' efforts to
attract allies. Emphasis is placed on two ways that social
structures are transformed so as to affect coalition-building
possibilities: how exporters fearing the loss of preferential
market access may be converted into allies of transnational drug
firms, and differential patterns of adjustment among state and
societal actors that are inspired by the introduction of new
policies. It is within the changing structural conditions produced
by these two processes that political leaders build coalitions in
support of different forms of compliance.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.